CEREZYME Side Effects

7022339-6 | Respiratory Failure
on Sep 28, 2010 Male patient from TURKEY , weighting 17.42 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: respiratory failure. Cerezyme dosage: 50 U/kg, Q2w.

6972550-5 | Laboratory Test Abnormal
Patient was taking Cerezyme (View Usage). Patient had the following side effects: laboratory test abnormal on Sep 08, 2010 from GREECE Additional patient health information: Female patient , weighting 127.9 lb, was diagnosed with gaucher's disease and. Cerezyme dosage: 21 U/kg, Q2w.

6955975-3 | Adverse Event, Gastrointestinal Haemorrhage, Myocardial Infarction
Adverse event was reported on Aug 24, 2010 by a Male patient taking Cerezyme (View Usage) (Dosage: 2400 U, Q2w) was diagnosed with gaucher's disease and. Location: UNITED STATES , weighting 205.5 lb, After Cerezyme was administered, patient had the following side effects: adverse event, gastrointestinal haemorrhage, myocardial infarction. During the same period patient was treated with COUMADIN (Unk) (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6941313-9 | Gastrointestinal Carcinoma
on Aug 13, 2010 Female patient from BRAZIL , 75 years of age, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal carcinoma. Cerezyme dosage: Unk.


6934023-5 | Gastrointestinal Carcinoma
on Aug 16, 2010 Female patient from BRAZIL , 75 years of age, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient had the following side effects: gastrointestinal carcinoma. Cerezyme dosage: Unk.

6928373-6 | Blood Alkaline Phosphatase Increased, Eye Rolling, Haemoglobin Decreased, Infusion Related Reaction, Platelet Count Decreased
Patient was taking Cerezyme (View Usage). After Cerezyme was administered, patient had the following side effects: blood alkaline phosphatase increased, eye rolling, haemoglobin decreased, infusion related reaction, platelet count decreased on Aug 06, 2010 from FRANCE Additional patient health information: Male patient , 63 years of age, weighting 198.4 lb, was diagnosed with gaucher's disease and. Cerezyme dosage: 2000 U, Intravenous. During the same period patient was treated with PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6928345-1 | Chronic Hepatic Failure, Hepatic Encephalopathy, Hepatic Fibrosis, Liver Transplant, Oesophageal Varices Haemorrhage, Portal Shunt
Adverse event was reported on Aug 05, 2010 by a Male patient taking Cerezyme (View Usage) (Dosage: ) was diagnosed with gaucher's disease and. Location: UNITED KINGDOM , 33 years of age, Patient experienced the following unwanted or unexpected effects: chronic hepatic failure, hepatic encephalopathy, hepatic fibrosis, liver transplant (What is liver transplant?), oesophageal varices haemorrhage, portal shunt.

6926201-6 | Abortion Spontaneous, Pregnancy
on Aug 05, 2010 Female patient from ROMANIA , 30 years of age, weighting 136.7 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient had the following side effects: abortion spontaneous, pregnancy (What is pregnancy?). Cerezyme dosage: 1800 U, Intravenous.

6923485-5 | Ascites, Cholelithiasis, Chronic Hepatic Failure, Liver Transplant, Oesophageal Varices Haemorrhage, Portal Vein Thrombosis
on Aug 05, 2010 Female patient from UNITED KINGDOM , 51 years of age, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). After Cerezyme was administered, patient had the following side effects: ascites, cholelithiasis, chronic hepatic failure, liver transplant (What is liver transplant?), oesophageal varices haemorrhage, portal vein thrombosis. Cerezyme dosage: . Patient was hospitalized.

6923484-3 | Chronic Hepatic Failure, Liver Transplant, Oesophageal Varices Haemorrhage
Patient was taking Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: chronic hepatic failure, liver transplant (What is liver transplant?), oesophageal varices haemorrhage on Aug 05, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 18 years of age, was diagnosed with gaucher's disease and. Cerezyme dosage: Unk.

6918596-4 | Pyrexia, Respiratory Disorder, Vomiting
Adverse event was reported on Oct 28, 2009 by a Male patient taking Cerezyme (View Usage) (Dosage: Intravenous) was diagnosed with gaucher's disease and. Location: UNITED STATES , child 4 years of age, Patient had the following side effects: pyrexia, respiratory disorder, vomiting. Patient was hospitalized.

6918595-2 | Dyspnoea, Fatigue, Pyrexia
on Dec 18, 2009 Female patient from UNITED STATES , 37 years of age, weighting 106.0 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). After Cerezyme was administered, patient had the following side effects: dyspnoea, fatigue, pyrexia. Cerezyme dosage: 30 U/kg, Qw, Intravenous. During the same period patient was treated with ORAL CONTRACEPTIVE NOS (ORAL CONTRACEPTIVE NOS) (View Oral Contraceptive Nos (oral Contraceptive Nos) Review and Oral Contraceptive Nos (oral Contraceptive Nos) Label ).

6918594-0 | Pneumonia
on Jun 24, 2009 Male patient from UNITED STATES , child 12 years of age, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?). Cerezyme dosage: 3200 U, Q2w, Intravenous. Patient was hospitalized.

6918571-X | Back Pain
Patient was taking Cerezyme (View Usage). Patient had the following side effects: back pain (What is back pain?) on Sep 24, 2009 from UNITED STATES Additional patient health information: Male patient , 38 years of age, was diagnosed with gaucher's disease and. Cerezyme dosage: 3600 U, Q2w, Intravenous.

6918570-8 | Pulmonary Hypertension
Adverse event was reported on Aug 17, 2009 by a Male patient taking Cerezyme (View Usage) (Dosage: 4500 U, Q2w, Intravenous) was diagnosed with gaucher's disease and. Location: UNITED STATES , 75 years of age, weighting 63.49 lb, After Cerezyme was administered, patient had the following side effects: pulmonary hypertension (What is pulmonary hypertension?). During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), CALCIUM AND ERGOCALCIFEROL (CALCIUM LACTATE, CALCIUM PHOSPHATE, ERGOCA (View Calcium And Ergocalciferol (calcium Lactate, Calcium Phosphate, Ergoca Review and Calcium And Ergocalciferol (calcium Lactate, Calcium Phosphate, Ergoca Label ), FISH OIL (FISH OIL) (View Fish Oil (fish Oil) Review and Fish Oil (fish Oil) Label ).

6884127-0 | Breech Extraction, Caesarean Section, Imminent Abortion, Pregnancy
on Jul 20, 2010 Female patient from ROMANIA , 38 years of age, weighting 91.49 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: breech extraction, caesarean section, imminent abortion, pregnancy (What is pregnancy?). Cerezyme dosage: 60 U/kg, Q2w, Intravenous. During the same period patient was treated with CALCIUM (CALCIUM) (View Calcium (calcium) Review and Calcium (calcium) Label ).

6876947-3 | Bone Disorder, Carpal Tunnel Syndrome, Epicondylitis, Nerve Compression, Vertigo
on Jul 13, 2010 Female patient from UNITED STATES , weighting 100.2 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient had the following side effects: bone disorder, carpal tunnel syndrome (What is carpal tunnel syndrome?), epicondylitis, nerve compression, vertigo. Cerezyme dosage: 2000 U, Q2w. During the same period patient was treated with ADVIL LIQUI GELS (Unk) (View Advil Liqui-gels Review and Advil Liqui-gels Label ).

6871027-5 | Convulsion, Weight Decreased
Patient was taking Cerezyme (View Usage). After Cerezyme was administered, patient had the following side effects: convulsion, weight decreased on Jul 15, 2010 from SINGAPORE Additional patient health information: Female patient , weighting 92.59 lb, was diagnosed with gaucher's disease, convulsion and. Cerezyme dosage: 40 U/kg, Q2w. During the same period patient was treated with ZONISAMIDE (100 Mg, Qd) (View Zonisamide Review and Zonisamide Label ), CLONAZEPAM (0.5 Mg, Tid) (View Clonazepam Review and Clonazepam Label ), VALPROIC ACID (300 Mg, Bid) (View Valproic Acid Review and Valproic Acid Label ), OXCARBAZEPINE (600 Mg, Bid) (View Oxcarbazepine Review and Oxcarbazepine Label ), LEVETIRACETAM (500 Mg, Bid) (View Levetiracetam Review and Levetiracetam Label ).

6866603-X | Blood Count Abnormal, Hip Arthroplasty
Adverse event was reported on Jul 18, 2010 by a Female patient taking Cerezyme (View Usage) (Dosage: Unk) was diagnosed with gaucher's disease and. Location: CANADA , weighting 134.5 lb, Patient experienced the following unwanted or unexpected effects: blood count abnormal, hip arthroplasty.

6856461-1 | Coronary Artery Occlusion, Thrombocytopenia
on Jul 13, 2010 Female patient from UNITED STATES , weighting 143.3 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient had the following side effects: coronary artery occlusion, thrombocytopenia. Cerezyme dosage: 2000 U, Q2w.

6835881-5 | Bone Disorder, Carpal Tunnel Syndrome, Epicondylitis, Nerve Compression, Vertigo
on Jun 30, 2010 Female patient from UNITED STATES , weighting 100.2 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). After Cerezyme was administered, patient had the following side effects: bone disorder, carpal tunnel syndrome (What is carpal tunnel syndrome?), epicondylitis, nerve compression, vertigo. Cerezyme dosage: 400 U, Q2w. During the same period patient was treated with ADVIL LIQUI GELS (Unk) (View Advil Liqui-gels Review and Advil Liqui-gels Label ).

6817885-1 | Convulsion
Patient was taking Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion on Jun 25, 2010 from SINGAPORE Additional patient health information: Female patient , weighting 101.4 lb, was diagnosed with gaucher's disease, convulsion and. Cerezyme dosage: 40 U/kg, Unk. During the same period patient was treated with ZONISAMIDE (100 Mg, Qd) (View Zonisamide Review and Zonisamide Label ), CLONAZEPAM (0.5 Mg, Tid) (View Clonazepam Review and Clonazepam Label ), VALPROIC ACID (300 Mg, Bid) (View Valproic Acid Review and Valproic Acid Label ), OXCARBAZEPINE (600 Mg, Bid) (View Oxcarbazepine Review and Oxcarbazepine Label ), LEVETIRACETAM (500 Mg, Bid) (View Levetiracetam Review and Levetiracetam Label ).

6816446-8 | Multiple Sclerosis
Adverse event was reported on Jun 15, 2010 by a Female patient taking Cerezyme (View Usage) (Dosage: 3400 U, Q2w, Intravenous) was diagnosed with gaucher's disease and. Location: UNITED STATES , 48 years of age, weighting 125.2 lb, Patient had the following side effects: multiple sclerosis (What is multiple sclerosis?). During the same period patient was treated with COPAXONE (View Copaxone Review and Copaxone Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LISINOPRIL AND HYDROCHLOROTHIAZIDE (View Lisinopril And Hydrochlorothiazide Review and Lisinopril And Hydrochlorothiazide Label ), BYSTOLIC (BYSTOLIC) (View Bystolic (bystolic) Review and Bystolic (bystolic) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATIVAN (View Ativan Review and Ativan Label ). Patient was hospitalized.

6810289-7 |
on Jun 22, 2010 Male patient from CANADA , child 2 years of age, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). . Cerezyme dosage: 600 U, Q2w.

6799504-6 | Pregnancy
on Jun 10, 2010 Female patient from ROMANIA , 30 years of age, weighting 136.7 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: pregnancy (What is pregnancy?). Cerezyme dosage: 1800 U, Intravenous.

6796994-X | Caesarean Section, Imminent Abortion
Patient was taking Cerezyme (View Usage). Patient had the following side effects: caesarean section, imminent abortion on Jun 03, 2010 from ROMANIA Additional patient health information: Female patient , 38 years of age, weighting 91.49 lb, was diagnosed with gaucher's disease and. Cerezyme dosage: 60 Ug,q2w, Intravenous. During the same period patient was treated with NO SPA (DROTAVERINE) (View No-spa (drotaverine) Review and No-spa (drotaverine) Label ), CALCIUM (CALCIUM) (View Calcium (calcium) Review and Calcium (calcium) Label ).

6756005-9 | Infusion Related Reaction
Adverse event was reported on May 27, 2010 by a Male patient taking Cerezyme (View Usage) (Dosage: 30 U/kg, Unk) was diagnosed with gaucher's disease and. Location: BRAZIL , 56 years of age, After Cerezyme was administered, patient had the following side effects: infusion related reaction.

6749114-1 | Eosinophilia, Pancreatic Carcinoma
on May 20, 2010 Female patient from UNITED STATES , weighting 126.8 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: eosinophilia, pancreatic carcinoma. Cerezyme dosage: 3200 U, Q2w.

6746388-8 | Convulsion
on May 19, 2010 Female patient from SINGAPORE , weighting 101.4 lb, was diagnosed with gaucher's disease, convulsion and was treated with Cerezyme (View Usage). Patient had the following side effects: convulsion. Cerezyme dosage: 40 U/kg, Unk. During the same period patient was treated with ZONISAMIDE (100 Mg, Qd) (View Zonisamide Review and Zonisamide Label ), CLONAZEPAM (0.5 Mg, Tid) (View Clonazepam Review and Clonazepam Label ), VALPROIC ACID (300 Mg, Bid) (View Valproic Acid Review and Valproic Acid Label ), OXCARBAZEPINE (600 Mg, Bid) (View Oxcarbazepine Review and Oxcarbazepine Label ), LEVETIRACETAM (500 Mg, Bid) (View Levetiracetam Review and Levetiracetam Label ).

6740514-2 | Hip Arthroplasty
Patient was taking Cerezyme (View Usage). After Cerezyme was administered, patient had the following side effects: hip arthroplasty on May 17, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 125.7 lb, was diagnosed with gaucher's disease and. Cerezyme dosage: 60 U/kg, Q2w.

6740137-5 | Gaucher's Disease, Osteoporosis, Pain, Spinal Compression Fracture
Adverse event was reported on May 17, 2010 by a Male patient taking Cerezyme (View Usage) (Dosage: 400 U, Qw) was diagnosed with gaucher's disease, hypertension and. Location: NETHERLANDS , weighting 149.9 lb, Patient experienced the following unwanted or unexpected effects: gaucher's disease, osteoporosis (What is osteoporosis?), pain (What is pain?), spinal compression fracture. During the same period patient was treated with HYDROCHLOROTHIAZIDE (15 Mg, Qd) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), COZAAR (50 Mg, Qd) (View Cozaar Review and Cozaar Label ).

6727436-8 | Convulsion
on May 13, 2010 Female patient from SINGAPORE , 26 years of age, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient had the following side effects: convulsion. Cerezyme dosage: .

6717229-X | Hip Fracture, Impaired Healing
on Apr 26, 2010 Female patient from UNITED STATES , 44 years of age, weighting 145.5 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). After Cerezyme was administered, patient had the following side effects: hip fracture, impaired healing. Cerezyme dosage: 1600 U, Q2w, Intravenous. Patient was hospitalized.

6712857-X | Cardiac Arrest, Tachycardia
Patient was taking Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), tachycardia on May 04, 2010 from ISRAEL Additional patient health information: Female patient , weighting 108.9 lb, was diagnosed with gaucher's disease and. Cerezyme dosage: 60 U/kg, Q4w. During the same period patient was treated with COUMADIN (5 Mg, Unk) (View Coumadin Review and Coumadin Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6703472-2 | Acute Respiratory Failure, Bronchitis, Epilepsy, Gastroenteritis, Pneumonia
Adverse event was reported on Apr 22, 2010 by a Male patient taking Cerezyme (View Usage) (Dosage: 800 U, Q2w, Intravenous) was diagnosed with gaucher's disease and. Location: JAPAN , child 6 years of age, weighting 35.27 lb, Patient had the following side effects: acute respiratory failure, bronchitis (What is bronchitis?), epilepsy (What is epilepsy?), gastroenteritis (What is gastroenteritis?), pneumonia (What is pneumonia?).

6703063-3 | Abdominal Pain, Chest Discomfort, Conjunctival Hyperaemia, Dyspnoea, Hypotension, Muscle Spasms, Rash, Rash Erythematous, Respiratory Distress
on Apr 15, 2010 Male patient from LIBYAN ARAB JAMAHIRIYA , 28 years of age, weighting 132.3 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). After Cerezyme was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), chest discomfort, conjunctival hyperaemia, dyspnoea, hypotension, muscle spasms, rash (What is rash?), rash erythematous, respiratory distress. Cerezyme dosage: 600 Iu, Q2w, Intravenous.

6703061-X | Atelectasis, Conductive Deafness, Cough, Dyspnoea, Extrinsic Vascular Compression, Femur Fracture, Glaucoma, Hypertension, Mediastinal Disorder
on Apr 20, 2010 Female patient from GERMANY , 47 years of age, weighting 112.4 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: atelectasis, conductive deafness, cough, dyspnoea, extrinsic vascular compression, femur fracture, glaucoma (What is glaucoma?), hypertension, mediastinal disorder. Cerezyme dosage: 4000 U, Intravenous. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), ALPHAGAN (View Alphagan Review and Alphagan Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ).

6700702-8 | Hip Arthroplasty
Patient was taking Cerezyme (View Usage). Patient had the following side effects: hip arthroplasty on Apr 19, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 125.7 lb, was diagnosed with gaucher's disease and. Cerezyme dosage: 60 U/kg, Q2w.

6698501-9 | Activated Partial Thromboplastin Time Prolonged, Hip Arthroplasty, International Normalised Ratio Increased, Medical Device Complication
Adverse event was reported on Apr 20, 2010 by a Female patient taking Cerezyme (View Usage) (Dosage: 50 U/kg, Unk) was diagnosed with gaucher's disease and. Location: UNITED STATES , weighting 194.0 lb, After Cerezyme was administered, patient had the following side effects: activated partial thromboplastin time prolonged, hip arthroplasty, international normalised ratio increased, medical device complication.

6687046-8 | Arrhythmia, Cardiac Arrest, Tachycardia
on Apr 06, 2010 Female patient from ISRAEL , weighting 108.9 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), cardiac arrest (What is cardiac arrest?), tachycardia. Cerezyme dosage: 60 U/kg, Q4w. During the same period patient was treated with COUMADIN (5 Mg, Unk) (View Coumadin Review and Coumadin Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ).

6669405-2 | Multiple Sclerosis Relapse
on Mar 22, 2010 Female patient from UNITED STATES , 48 years of age, weighting 125.2 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient had the following side effects: multiple sclerosis relapse. Cerezyme dosage: 3400 U, Q2w, Intravenous. During the same period patient was treated with COPAXONE (View Copaxone Review and Copaxone Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LISINOPRIL AND HYDROCHLOROTHIAZIDE (View Lisinopril And Hydrochlorothiazide Review and Lisinopril And Hydrochlorothiazide Label ), BYSTOLIC (BYSTOLIC) (View Bystolic (bystolic) Review and Bystolic (bystolic) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATIVAN (View Ativan Review and Ativan Label ). Patient was hospitalized.

6667058-0 | Economic Problem, Eye Injury, Road Traffic Accident
Patient was taking Cerezyme (View Usage). After Cerezyme was administered, patient had the following side effects: economic problem, eye injury, road traffic accident on Mar 22, 2010 from UNITED STATES Additional patient health information: Female patient , 73 years of age, weighting 93.92 lb, was diagnosed with gaucher's disease and. Cerezyme dosage: 500 U, Intervenous. During the same period patient was treated with BETA BLOCKING AGENTS (View Beta Blocking Agents Review and Beta Blocking Agents Label ).

6663809-X |
Adverse event was reported on Mar 25, 2010 by a Male patient taking Cerezyme (View Usage) (Dosage: 60 U/kg, Unk) was diagnosed with gaucher's disease and. Location: TURKEY , weighting 15.43 lb, .

6662108-X | Parkinson's Disease
on Mar 26, 2010 Female patient from UNITED STATES , weighting 185.2 lb, was diagnosed with gaucher's disease, osteopenia, lipids abnormal and was treated with Cerezyme (View Usage). Patient had the following side effects: parkinson's disease (What is parkinson's disease?). Cerezyme dosage: 3000 U, Q2w. During the same period patient was treated with FOSAMAX (70 Mg, Qw) (View Fosamax Review and Fosamax Label ), LIPITOR (100 Mg, Qd) (View Lipitor Review and Lipitor Label ), ASPIRIN (81 Mg, Qd) (View Aspirin Review and Aspirin Label ), ENABLEX (15 Mg, Qd) (View Enablex Review and Enablex Label ), DIOVAN (60 Mg, Bid) (View Diovan Review and Diovan Label ).

6656260-X | Epistaxis, Hepatomegaly, Nephritic Syndrome, Proteinuria, Swelling
on Mar 18, 2010 Male patient from ARGENTINA , 20 years of age, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). After Cerezyme was administered, patient had the following side effects: epistaxis, hepatomegaly, nephritic syndrome, proteinuria, swelling. Cerezyme dosage: . During the same period patient was treated with LOTRIAL (Unk) (View Lotrial Review and Lotrial Label ).

6639941-3 | Abdominal Pain, Chest Discomfort, Conjunctival Hyperaemia, Hypotension, Muscle Spasms, Rash Erythematous, Respiratory Distress, Syncope
Patient was taking Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), chest discomfort, conjunctival hyperaemia, hypotension, muscle spasms, rash erythematous, respiratory distress, syncope on Mar 07, 2010 from LIBYAN ARAB JAMAHIRIYA Additional patient health information: Male patient , 28 years of age, weighting 132.3 lb, was diagnosed with gaucher's disease and. Cerezyme dosage: 3600 Iu, Q2w, Intravenous; 3600 Iu, Q2w, Intravenous.

6639229-0 | Atrial Fibrillation
Adverse event was reported on Mar 03, 2010 by a Male patient taking Cerezyme (View Usage) (Dosage: 3200 U, Q2w, Intravenous; 800 U, Q4w, Intravenous) was diagnosed with gaucher's disease and. Location: UNITED STATES , 35 years of age, weighting 162.0 lb, Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?). During the same period patient was treated with . (View . Review and . Label ). Patient was hospitalized.

6637699-5 | Cataract, Eye Disorder, Gout, Intervertebral Disc Protrusion, Periarthritis, Pulmonary Hypertension
on Mar 11, 2010 Male patient from UNITED STATES , weighting 143.3 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). After Cerezyme was administered, patient had the following side effects: cataract (What is cataract?), eye disorder, gout (What is gout?), intervertebral disc protrusion, periarthritis, pulmonary hypertension (What is pulmonary hypertension?). Cerezyme dosage: 2800 U, Q2w.

6634158-0 | Disease Progression, Gaucher's Disease, Normal Pressure Hydrocephalus, Pulmonary Hypertension
on Feb 23, 2010 Female patient from FRANCE , 81 years of age, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression, gaucher's disease, normal pressure hydrocephalus, pulmonary hypertension (What is pulmonary hypertension?). Cerezyme dosage: .

6631108-8 |
Patient was taking Cerezyme (View Usage). on Mar 03, 2010 from UNITED STATES Additional patient health information: Male patient , 63 years of age, weighting 145.5 lb, was diagnosed with gaucher's disease and. Cerezyme dosage: 2000 U, Q2w, Intravenous.